EGC CEO, Dr. Eva Garland, moderated a panel titled “Executing My Award” at the SBIR/STTR Spring Innovation Conference.
Accelerating development of innovative technologies
EGC’s extraordinary team of scientists and accountants are ready to secure and manage non-dilutive funding to support your scientific innovations. Contact us to learn more.
Related Posts
September 26, 2023
EGC’s Dr. Heaney Presented at BioVenture Nexus in LA
The EGC Team attended the BioVenture Nexus conference in Los Angeles. BioVenture Nexus is the premier event for innovation and networking in the…
August 18, 2023
EGC Receives Six-Time Inc. 5000 Recognition
Eva Garland Consulting, LLC (EGC) is excited once again to be named as one of the fastest growing privately owned companies in the United States by…
August 9, 2023
EGC’s Leadership of NIH AAP Enters 5th Year
Eva Garland Consulting (EGC) is thrilled to extend our partnership with the National Institutes of Health (NIH) to support small businesses in…
June 22, 2023
EGC Presented at a NCATS Workshop on Non-Dilutive Funding
Dr. Xiaohu (Tiger) Xie, a Scientific Grants Expert from EGC, presented a talk titled “Application Tips & Resources to Help Secure SBIR & STTR…